|
|
||||||||
Equipe de Physiopathologie Cellulaire Cardiaque et Laboratorie d'Etude des Radiopharmaceutiques, Université Joseph Fourier, Grenoble, France
CIS Bio International, Gif sur Yvette, France
Correspondence: For correspondence or reprints contact: Daniel Fagret, MD, Laboratorie d'Etude des Radiopharmaceutiques, URA CNRS 1287, Faculté de Médecine de Grenoble, 38700 La Tronche, France.
ABSTRACT
[Bis (N-etoxy, N ethyl dithiocarbamato) nitrido] 99mTc (V) (TcN-NOET) is a new neutral lipophilic myocardial imaging agent proposed for clinical use for detecting coronary artery disease. We studied the relation between myocardial retention of TcN-NOET and myocardial blood flow (MBF) in a canine model. Methods: A wide range of MBF was induced by partial regional coronary occlusion and dipyridamole infusion (protocols 1, 2 and 3). Myocardial activity of TcN-NOET was determined by in vitro tissue counting at 15 or 90 min postinjection. Tracer activity was correlated with radiolabeled microspheres using linear regression analysis. Results: There was a linear correlation between myocardial TcN-NOET activity and microspheres in protocol 1 (r = 094, 15 min postinjection, protocol 2 (r = 0.94, 15 min postinjection after dipyridamole) and protocol 3 (r = 0.91 , 90 min postinjection after dipyridamole). When arterial occlusion was discontinued (protocol 4), there was no longer a close linear correlation (r = 0.26). The first-pass myocardial extraction action of TcN-NOET was 75.5% ± 4% under basal conditions and 85% ± 2% under hyperemic conditions (p < 0.01). Conclusion: Up to 90 min after injection, the relationship between TcN-NOET myocardial retention and blood flow is excellent over a wide range of flows. After reflow, TcN-NOET redistributes almost completely within 90 min.
Key Words: technetium-99m(N)-NOET myocardial retention myocardial blood flow coronary artery disease
This article has been cited by other articles:
![]() |
L. M. Riou, C. Ghezzi, G. Vanzetto, A. Broisat, J.-P. Mathieu, R. Bontron, R. Pasqualini, and D. Fagret Verapamil Does Not Inhibit 99mTcN-NOET Uptake In Situ in Normal or Ischemic Canine Myocardium J. Nucl. Med., June 1, 2003; 44(6): 981 - 987. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takehana, G. A. Beller, M. Ruiz, F. D. Petruzella, D. D. Watson, and D. K. Glover Assessment of Residual Coronary Stenoses Using 99mTc-N-NOET Vasodilator Stress Imaging to Evaluate Coronary Flow Reserve Early After Coronary Reperfusion in a Canine Model of Subendocardial Infarction J. Nucl. Med., September 1, 2001; 42(9): 1388 - 1394. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fagret, C. Ghezzi, and G. Vanzetto 99mTc-N-NOET Imaging for Myocardial Perfusion: Can It Offer More Than We Already Have? J. Nucl. Med., September 1, 2001; 42(9): 1395 - 1396. [Full Text] [PDF] |
||||
![]() |
G. Vanzetto, D. K. Glover, M. Ruiz, D. A. Calnon, R. Pasqualini, D. D. Watson, and G. A. Beller 99mTc-N-NOET Myocardial Uptake Reflects Myocardial Blood Flow and Not Viability in Dogs With Reperfused Acute Myocardial Infarction Circulation, May 23, 2000; 101(20): 2424 - 2430. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Calnon, M. Ruiz, G. Vanzetto, D. D. Watson, G. A. Beller, and D. K. Glover Myocardial Uptake of 99mTc-N-NOET and 201Tl During Dobutamine Infusion : Comparison With Adenosine Stress Circulation, October 12, 1999; 100(15): 1653 - 1659. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Riou, C. Ghezzi, O. Mouton, J.-P. Mathieu, R. Pasqualini, M. Comet, and D. Fagret Cellular Uptake Mechanisms of 99mTcN-NOET in Cardiomyocytes From Newborn Rats : Calcium Channel Interaction Circulation, December 8, 1998; 98(23): 2591 - 2597. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Vanzetto, D. A. Calnon, M. Ruiz, D. D. Watson, R. Pasqualini, G. A. Beller, and D. K. Glover Myocardial Uptake and Redistribution of 99mTc-N-NOET in Dogs With Either Sustained Coronary Low Flow or Transient Coronary Occlusion : Comparison With 201Tl and Myocardial Blood Flow Circulation, October 7, 1997; 96(7): 2325 - 2331. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |